When all siglecs were evaluated by a multivariate model using enter selection, siglec-2 overexpression is negatively associated with HCC patients’ AFP level (OR = 0.822, 95%CI = 0.724–0.934, P = 0.003). The gene discussed is AFP; the disease is hepatocellular carcinoma.